Bausch + Lomb announced today that it intends to bring its recently recalled enVista intraocular lenses (IOLs) back to the ...

Bausch + Lomb will return its enVista intraocular lenses to market following a voluntary recall in March after discovering they had certain production and material issues.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced it has identified the event that led to its ...

Yes, a doctor can remove and replace an intraocular lens (IOL), a procedure known as an IOL exchange. However, this approach is rarely necessary. According to a 2023 retrospective study ...

Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...

Bausch + Lomb (NYSE:BLCO) shares gained on Thursday after the company announced plans to relaunch its intraocular lenses ...

ZEISS Medical Technology continued to push the boundaries of surgical precision and workflow efficiency with the introduction ...

Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and ...

Intraocular lens damage can occur to optics and haptics and can occur intraoperatively and postoperatively. Intraocular lens malpositions include decentration, subluxation, partial and total ...

The company recalled all lots of its enVista Aspire, enVista Aspire Toric, enVista Envy and enVista Envy Toric intraocular lenses. Also included are the enVista monofocal and enVista monofocal ...